Ambiq Micro Q4 Sales $20.7M with 45.5% Margin, Eyes $100M+ 2026
Ambiq Micro’s Q4 net sales rose to $20.7 million (up 2% YoY, 14.2% sequentially) with non-GAAP gross margin expanding to 45.5%, while R&D spend jumped 33% to $9.3 million. The company targets 2026 revenue above $100 million, guiding Q1 sales of $21–22 million and boosting expenses by $30 million.
1. Q4 Financial Results
Ambiq Micro posted Q4 net sales of $20.7 million (up 2% YoY, 14.2% sequentially). Non-GAAP gross profit rose 75.5% to $9.4 million, boosting margin to 45.5%. R&D expense climbed 33% to $9.3 million while SG&A increased 19.7% to $7.3 million. Mainland China contributed 8.6% of sales, down from 50%.
2. Product Mix and Edge AI Adoption
Margin expansion was driven by a favorable product mix and broader deployment of edge AI solutions on the SPOT platform, including customer upgrades to the Apollo5 family. Executives noted that over 80% of units shipped in 2025 ran AI algorithms, and launches like Apollo510 Lite and HeliaAOT extend advanced AI capabilities.
3. 2025 Milestones and Balance Sheet
The quarter marked the highest net sales of fiscal 2025, capping a year of sequential revenue and gross profit growth. A $76.8 million follow-on share issuance boosted cash to $217.1 million and left the company debt-free, while interest income added $1.3 million to other income.
4. 2026 Guidance and Investment Plans
Ambiq Micro anticipates 2026 revenue above $100 million, guiding Q1 net sales of $21–22 million with 44%–45% gross margin. Operating expenses will rise by about $30 million, including $7–10 million of IP purchases, to accelerate development of the Atomic and Apollo product families, with early-quarter strength expected.